Replies to post #495 on Capricor Therapeutics Inc (CAPR)

[staccani]

http://www.irdirect.net/prviewer/release/id/4042654
The meeting with the FDA is to discuss whether the 6 months interim data (which was presented in July), is enough to grant AA in addition to the cardiac and respiratory data . I guess today's additional data was necessary to complete the PUL 2.0 data with shoulder and distal at 6 months (mid level data was reported earlier)